+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Danshenxinkun A

SBP03254
65907-75-7
98%
普瑞法
Danshenxinkun A, Danshenxinkun B and Neocryptotanshinone may intervene thrombotic diseases by adjusting the targets mainly involved in pathways of endocrine system, signal transduction, signaling molecules and interaction, cell motility, environmental adaptation and nervous system. Oleoyl danshenxinkun A also selectively inhibits rabbit platelet aggregation induced by arachidonic acid.
Catalog No Package Original Price Price Inventory Quantity Operating
SBP03254-5mg 5mg
SBP03254-10mg 10mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Danshenxinkun A Related Products

Product drug property prediction parameters

  • 74.6000

  • 2.9029

  • .4551

  • .0188

  • 3.7468

  • 26.3489

  • Low

  • 91.6243

  • 3.0768

  • Yes

  • No

  • No

  • No

  • Yes

  • Yes

  • 0.9

  • Yes

  • No

  • No

  • No